MyHealthChecked (LON:MHC) Trading 1.7% Higher – Should You Buy?

MyHealthChecked PLC (LON:MHCGet Free Report)’s stock price was up 1.7% on Tuesday . The company traded as high as GBX 9.15 and last traded at GBX 9.15. Approximately 57,186 shares were traded during trading, an increase of 33% from the average daily volume of 42,954 shares. The stock had previously closed at GBX 9.

MyHealthChecked Stock Performance

The firm’s 50 day simple moving average is GBX 9.25 and its 200 day simple moving average is GBX 10.73. The firm has a market cap of £4.76 million, a PE ratio of -2.43 and a beta of 1.37. The company has a current ratio of 12.22, a quick ratio of 2.00 and a debt-to-equity ratio of 0.16.

MyHealthChecked (LON:MHCGet Free Report) last released its quarterly earnings data on Friday, September 26th. The company reported GBX (2.62) EPS for the quarter. MyHealthChecked had a negative net margin of 11.06% and a negative return on equity of 12.80%.

About MyHealthChecked

(Get Free Report)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness.

Featured Stories

Receive News & Ratings for MyHealthChecked Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyHealthChecked and related companies with MarketBeat.com's FREE daily email newsletter.